Gastrointestinal Tumors is a reputable, peer-reviewed journal dedicated to advancing knowledge in the field of gastrointestinal oncology. Published by KARGER, this journal has been a pivotal platform since its transition to Open Access in 2014, ensuring that research findings are accessible to a global audience of researchers, clinicians, and students engaged in this vital area of study. With an emphasis on innovative research, clinical studies, and comprehensive reviews, Gastrointestinal Tumors aims to bridge gaps in knowledge and foster discussions that will inform and enhance clinical practices. The journal's commitment to excellence reflects the rising importance of gastrointestinal health in medical research, making it an essential resource for anyone seeking to stay at the forefront of this rapidly evolving field. Based in Basel, Switzerland, it is positioned within a strong academic community, and continues to influence the landscape of gastrointestinal cancer research.

Reproductive Medicine is an esteemed open-access journal published by MDPI, focusing on the latest research and advances in reproductive health, fertility, and assisted reproductive technologies. With its E-ISSN of 2673-3897, the journal aims to provide a platform for researchers, clinicians, and healthcare professionals to disseminate their findings, share innovative practices, and engage in scholarly discourse. Situated in Basel, Switzerland, Reproductive Medicine emphasizes a multidisciplinary approach, exploring biological, clinical, and psychological aspects of reproductive health. Although the journal is in the early stages of establishing metrics such as H-index and Scopus rankings, its open-access model enhances accessibility, allowing for a broad dissemination of knowledge. Committed to fostering advancements in the field, Reproductive Medicine is essential for those seeking to stay at the forefront of reproductive health research.

Fetal and Pediatric Pathology, an esteemed journal published by TAYLOR & FRANCIS INC, is dedicated to advancing the field of pediatric and fetal medicine through the dissemination of high-quality research and clinical insights. With an ISSN of 1551-3815 and an E-ISSN of 1551-3823, the journal has been a key resource for researchers and practitioners since its inception in 1983. Based in the United Kingdom, it covers a broad spectrum of topics relevant to Medicine, Pathology and Forensic Medicine, and Pediatrics, Perinatology, and Child Health, consistently reflecting on contemporary challenges faced in these fields. The journal has attained a commendable Q3 ranking within its categories as of 2023, underlining its relevance in the academic community. Though not an open-access publication, the research presented in Fetal and Pediatric Pathology plays a pivotal role in informing practice, guiding future studies, and enhancing the understanding of diseases affecting fetuses and children. Its convergence of research throughout multiple years, continuing until 2024, marks it as a crucial platform for ongoing scientific dialogue and innovation, aimed at fostering better health outcomes for younger populations.

DNA RESEARCH is a pioneering open-access journal published by Oxford University Press, dedicated to advancing the field of genetics and molecular biology. Since its inception in 1994, the journal has been at the forefront of scientific innovation, providing a global platform for researchers to publish high-quality findings that drive the understanding of DNA and its implications in medicine. With an impactful presence characterized by a Q2 ranking in Genetics, a Q1 ranking in Medicine (miscellaneous), and a Q2 ranking in Molecular Biology as per the latest 2023 assessments, DNA RESEARCH stands as a vital resource for both established scholars and emerging scientists. The journal's diverse range of articles caters to a wide audience, fostering collaboration and the sharing of knowledge. Researchers, professionals, and students alike will find an abundance of cutting-edge research and insights that can inform their work and further their understanding of this critical scientific domain. For more information and to access articles, visit the journal's website at Oxford University Press.

CYTOGENETIC AND GENOME RESEARCH is a pivotal journal dedicated to the exploration of cytogenetics, genomics, and their applications within clinical genetics and molecular biology. Published by KARGER in Switzerland, this journal aims to foster comprehensive discussions and disseminate impactful research from diverse fields related to genetics. It operates under an open access model, ensuring that researchers, professionals, and students can easily access and contribute to the latest findings. With coverage spanning from 1962 to 2024, CYTOGENETIC AND GENOME RESEARCH continues to serve as a vital resource, despite its current categorization in the Q4 quartile across Genetics and Molecular Biology. It provides an avenue for advancing the understanding of genomic mechanisms and their implications for human health. The journal encourages submissions that delve into cutting-edge methodologies, data interpretation, and theoretical frameworks, thereby playing a crucial role in the advancement of genetic research and its clinical applications.

Molecular Syndromology is a premier journal focused on the intricate connections between molecular genetics and syndromology, fostering discussions that advance our understanding of genetic disorders and their clinical implications. Published by KARGER, a distinguished name in medical and scientific publishing, this journal serves as a valuable platform for researchers, clinicians, and students in the field of genetics. With its ISSN 1661-8769 and E-ISSN 1661-8777, the journal has gained recognition in its category, currently positioned in the Q4 quartile for both genetic and clinical genetics disciplines according to the latest metrics. Despite being indexed lower in Scopus rankings, it addresses crucial gaps in research and offers open access options that enhance visibility and dissemination of knowledge. As it continues to converge from 2010 to 2024, Molecular Syndromology aims to bridge the gap between molecular research and its clinical applications, making a significant impact in the evolving landscape of genetic medicine.

Comparative Cytogenetics, an esteemed journal published by PENSOFT PUBLISHERS, is a pivotal resource in the fields of animal science, biotechnology, genetics, insect science, and plant science. Since its inception as an Open Access journal in 2009, it has significantly contributed to the democratization of scientific knowledge, allowing researchers and students across the globe to access cutting-edge developments in cytogenetics. With an impressive range of articles published from 2010 to 2024, this journal has achieved a commendable impact within the academic community, earning a Q3 ranking in Animal Science and Zoology, Biotechnology, and Insect Science, as well as a Q4 ranking in Genetics, indicating its growing influence. Its Scopus rankings reflect a solid standing, with notable percentiles showcasing its relevance across diverse biological sciences. Located in Sofia, Bulgaria, Comparative Cytogenetics serves not only to disseminate research but also to foster collaboration in understanding cytogenetic dynamics, making it an essential platform for professionals, researchers, and students alike.

GENES CHROMOSOMES & CANCER, published by Wiley, is a premier journal in the intertwined fields of cancer research and genetics. With an ISSN of 1045-2257 and an e-ISSN of 1098-2264, this journal has been a significant outlet for innovative research since its inception in 1989, continuing through to 2024. Positioned in the Q2 quartile of both Cancer Research and Genetics categories in 2023, it reflects a strong impact in the scientific community, as evidenced by its Scopus rankings—99th in Genetics and 83rd in Cancer Research. Though it does not provide open access options, GENES CHROMOSOMES & CANCER offers valuable insights that foster collaboration and discovery among researchers, professionals, and students dedicated to understanding the genetic underpinnings of cancer. With its reputable standing, this journal is a vital resource for those aspiring to contribute meaningful advancements in cancer genetics and therapeutic interventions.

CLINICAL DYSMORPHOLOGY, published by Lippincott Williams & Wilkins, is a pivotal journal in the fields of anatomy, genetics, and pediatric health, with a significant focus on the study of congenital disorders and their phenotypic manifestations. Established in 1992, this esteemed journal has contributed valuable insights into the understanding of dysmorphic syndromes and their clinical implications, making it an essential resource for researchers, clinicians, and students alike. With an impact factor indicative of its robust scholarly influence, CLINICAL DYSMORPHOLOGY engages a diverse readership through specialized articles, case studies, and reviews that advance the knowledge of genetic conditions and associated anatomical anomalies. Although it operates under a non-open access model, the journal is highly regarded with a 2023 ranking of Q3 in Anatomy and Q4 in several other relevant categories, reflecting its ongoing commitment to quality research in the domain of clinical medicine. Researchers and professionals are encouraged to contribute to and explore the rich content of this journal as it continues to shape the discourse in dysmorphology and related fields until its expected convergence in 2024.

Leukemia Research Reports, published by Elsevier Advanced Technology, is a prominent open-access journal dedicated to the latest advancements in the field of hematology and oncology. Since its launch in 2012, this journal has been a vital resource for researchers, healthcare professionals, and students aiming to disseminate and access high-quality research articles focused on various aspects of leukemia and related blood disorders. With an impact factor indicative of its significance in the field, Leukemia Research Reports currently holds a Q3 quartile ranking in both Hematology and Oncology, and is included in key databases such as Scopus. The journal not only embraces a commitment to open access, ensuring that research is freely available, but also actively promotes collaborations that strive to enhance our understanding and treatment of leukemia. Based in the United Kingdom, this journal continues to play a crucial role in fostering innovation and knowledge sharing within the medical community.